| Clinical data | |
|---|---|
| Other names | Dimenoxadol, Estocin |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C20H25NO3 |
| Molar mass | 327.424 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Dimenoxadol (INN; also known asdimenoxadole (BAN) ordimenoxadole; brand nameEstocin inRussia) is anopioidanalgesic which is abenzilic acid derivative, closely related tobenactyzine (ananticholinergic). Further, the structure is similar tomethadone and related compounds likedextropropoxyphene.
It was invented in Germany in the 1950s,[2] and produces similar effects to other opioids, includinganalgesia,sedation,dizziness andnausea.[3][4][5]
In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9617 and a 2013 annual aggregate manufacturing quota of zero.